Becton, Dickinson and Company
- BDX
- NYSE
- Medical - Instruments & Supplies
- Medical Devices/Supplies
- Diagnostics/Lab Equipment
$190.74
Today −0.53%Quote Oct 19, 2026, 08:00 PM UTC
+5.72%over the last month
Max drawdown −3.8%From 1-month high −1.0%3 months +24.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Becton, Dickinson and
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products.
Where the money comes from
Q1 2026 revenue $5.25B
- Life Sciences$2.50B47.6%
- Medical$2.40B45.7%
- Other / not reported$352.0M6.7%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Employees
72,000
Market value
$51.96B
Quote Oct 19
Floor
$188.79
1.0% below price
Resistance
$191.45
0.4% above price
Price vs analyst targets
34 analysts
Lowest target
$165.00Highest target
$210.00
$165.00Highest target
$210.00
- Price $190.74
- Average target $188.33
- Analysts' target range
Analysts' average target sits about 1% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BDXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free